Amneal Pharmaceuticals, Inc. Stock price
Equities
AMRX
US03168L1052
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.12 USD | +4.62% | +0.66% | +0.82% |
Mar. 25 | Amneal Pharma Gets FDA Nod for Infection Fighting Drug Combination | DJ |
Mar. 25 | Amneal Pharmaceuticals Receives FDA Approval for Ear Infection Treatment | MT |
Financials (USD)
Sales 2024 * | 2.6B | Sales 2025 * | 2.73B | Capitalization | 1.89B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | 22M | EV / Sales 2024 * | 1.61 x |
Net Debt 2024 * | 2.29B | Net Debt 2025 * | 2.07B | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
122
x | P/E ratio 2025 * |
68
x | Employees | 7,850 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.86% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | +4.62% | ||
1 week | +0.66% | ||
Current month | +10.87% | ||
1 month | +7.18% | ||
3 months | -1.45% | ||
6 months | +46.76% | ||
Current year | +0.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 6.12 | +4.62% | 1,913,485 |
24-03-26 | 5.85 | -1.02% | 1,895,661 |
24-03-25 | 5.91 | -2.64% | 889,275 |
24-03-22 | 6.07 | -3.50% | 2,228,526 |
24-03-21 | 6.29 | +3.45% | 1,029,832 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 1.89B | |
+9.16% | 45.97B | |
+54.26% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |